Proteintech

SPOP Polyclonal Antibody

SPOP Antibody in Immunocytochemistry (ICC/IF)

图: 1 / 8

SPOP Antibody (16750-1-AP) in ICC/IF

Immunofluorescent analysis of ( 10% Formaldehyde ) fixed HepG2 cells using 16750-1-AP (SPOP antibody) at dilution of 1:50 and Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IGG (H+L).

SPOP Antibody in Immunohistochemistry (Paraffin) (IHC (P))

Product Image Gallery

产品信息

16750-1-AP

应用

建议稀释比

已发表文章

免疫印迹 (WB)

1:500-1:2,000

查看57篇已发表文章 57篇已发表文章

免疫组化 (IHC)

查看10篇已发表文章 10篇已发表文章

免疫组化（石蜡） (IHC (P))

1:50-1:500

免疫细胞化学 (ICC/IF)

1:50-1:500

查看9篇已发表文章 9篇已发表文章

免疫沉淀 (IP)

Assay-dependent

查看10篇已发表文章 10篇已发表文章

RNA免疫共沉淀 (RIP)

查看1篇已发表文章 1篇已发表文章

不适用 (N/A)

查看2篇已发表文章 2篇已发表文章

产品规格

种属反应

Human, Mouse, Rat

已发表种属

Human, Mouse

宿主/亚型

Rabbit / IgG

分类

Polyclonal

类型

Antibody

抗原

SPOP Fusion Protein Ag10215 (1-374 aa encoded by BC003385)

查看免疫原

偶联物

Unconjugated Unconjugated Unconjugated

形式

Liquid

浓度

0.21 mg/mL

纯化类型

Antigen affinity chromatography

保存液

PBS, pH 7.3, with 50% glycerol

内含物

0.02% sodium azide

保存条件

-20°C

运输条件

Wet ice (domestic); Dry ice (international)

产品详细信息

Immunogen sequence: MSRVPSPPP PAEMSSGPVA ESWCYTQIKV VKFSYMWTIN NFSFCREEMG EVIKSSTFSS GANDKLKWCL RVNPKGLDEE SKDYLSLYLL LVSCPKSEVR AKFKFSILNA KGEETKAMES QRAYRFVQGK DWGFKKFIRR DFLLDEANGL LPDDKLTLFC EVSVVQDSVN ISGQNTMNMV KVPECRLADE LGGLWENSRF TDCCLCVAGQ EFQAHKAILA ARSPVFSAMF EHEMEESKKN RVEINDVEPE VFKEMMCFIY TGKAPNLDKM ADDLLAAADK YALERLKVMC EDALCSNLSV ENAAEILILA DLHSADQLKT QAVDFINYHA SDVLETSGWK SMVVSHPHLV AEAYRSLASA QCPFLGPPRK RLKQS (1-374 aa encoded by BC003385)

靶标信息

Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates the ubiquitination of target proteins, leading most often to their proteasomal degradation.

仅用于科研。不用于诊断过程。未经明确授权不得转售。

Product References

TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks.

Nature communications

Ma J,Zhou Y,Pan P,Yu H,Wang Z,Li LL,Wang B,Yan Y,Pan Y,Ye Q,Liu T,Feng X,Xu S,Wang K,Wang X,Jian Y,Ma B,Fan Y,Gao Y,Huang H,Li L

Fri Mar 31 00:00:00 EDT 2023

O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.

Oncogene

Zhou P,Chang WY,Gong DA,Huang LY,Liu R,Liu Y,Xia J,Wang K,Tang N,Huang AL

Wed Mar 01 00:00:00 EST 2023

O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.

Oncogene

Zhou P,Chang WY,Gong DA,Huang LY,Liu R,Liu Y,Xia J,Wang K,Tang N,Huang AL

Wed Mar 01 00:00:00 EST 2023

O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.

Oncogene

Zhou P,Chang WY,Gong DA,Huang LY,Liu R,Liu Y,Xia J,Wang K,Tang N,Huang AL

Wed Mar 01 00:00:00 EST 2023

O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.

Oncogene

Zhou P,Chang WY,Gong DA,Huang LY,Liu R,Liu Y,Xia J,Wang K,Tang N,Huang AL

Wed Mar 01 00:00:00 EST 2023

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.

The Journal of clinical investigation

Ding L,Chen X,Zhang W,Dai X,Guo H,Pan X,Xu Y,Feng J,Yuan M,Gao X,Wang J,Xu X,Li S,Wu H,Cao J,He Q,Yang B

Tue Jan 03 00:00:00 EST 2023

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.

The Journal of clinical investigation

Ding L,Chen X,Zhang W,Dai X,Guo H,Pan X,Xu Y,Feng J,Yuan M,Gao X,Wang J,Xu X,Li S,Wu H,Cao J,He Q,Yang B

Tue Jan 03 00:00:00 EST 2023

Additive Effect of CD73 Inhibitor in Colorectal Cancer Treatment With CDK4/6 Inhibitor Through Regulation of PD-L1.

Cellular and molecular gastroenterology and hepatology

Noh JY,Lee IP,Han NR,Kim M,Min YK,Lee SY,Yun SH,Kim SI,Park T,Chung H,Park D,Lee CH

Mon Sep 26 00:00:00 EDT 2022

A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity.

Science advances

Tawaratsumida K,Redecke V,Wu R,Kuriakose J,Bouchard JJ,Mittag T,Lohman BK,Mishra A,High AA,Häcker H

Fri Jul 08 00:00:00 EDT 2022

A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity.

Science advances

Tawaratsumida K,Redecke V,Wu R,Kuriakose J,Bouchard JJ,Mittag T,Lohman BK,Mishra A,High AA,Häcker H

Fri Jul 08 00:00:00 EDT 2022

A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity.

Science advances

Tawaratsumida K,Redecke V,Wu R,Kuriakose J,Bouchard JJ,Mittag T,Lohman BK,Mishra A,High AA,Häcker H

Fri Jul 08 00:00:00 EDT 2022

A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity.

Science advances

Tawaratsumida K,Redecke V,Wu R,Kuriakose J,Bouchard JJ,Mittag T,Lohman BK,Mishra A,High AA,Häcker H

Fri Jul 08 00:00:00 EDT 2022

CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.

Journal for immunotherapy of cancer

Dong M,Qian M,Ruan Z

Sat Oct 01 00:00:00 EDT 2022

CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.

Journal for immunotherapy of cancer

Dong M,Qian M,Ruan Z

Sat Oct 01 00:00:00 EDT 2022

Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function.

Cancer research

Zhao X,Wei Y,Chu YY,Li Y,Hsu JM,Jiang Z,Liu C,Hsu JL,Chang WC,Yang R,Chan LC,Qu J,Zhang S,Ying H,Yu D,Hung MC

Mon Jun 06 00:00:00 EDT 2022

Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1.

Medical science monitor : international medical journal of experimental and clinical research

Shi J,Cao J,Lu X,Fan L,Guo H,Fu J

Mon Apr 19 00:00:00 EDT 2021

SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Su S,Chen J,Jiang Y,Wang Y,Vital T,Zhang J,Laggner C,Nguyen KT,Zhu Z,Prevatte AW,Barker NK,Herring LE,Davis IJ,Liu P

Thu Jul 01 00:00:00 EDT 2021

SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.

Molecular cancer

Jiang Q,Zheng N,Bu L,Zhang X,Zhang X,Wu Y,Su Y,Wang L,Zhang X,Ren S,Dai X,Wu D,Xie W,Wei W,Zhu Y,Guo J

Thu Aug 05 00:00:00 EDT 2021

G3BP1 inhibits Cul3^SPOP to amplify AR signaling and promote prostate cancer.

Nature communications

Mukhopadhyay C,Yang C,Xu L,Liu D,Wang Y,Huang D,Deonarine LD,Cyrta J,Davicioni E,Sboner A,Robinson BD,Chinnaiyan AM,Rubin MA,Barbieri CE,Zhou P

Thu Nov 18 00:00:00 EST 2021

G3BP1 inhibits Cul3^SPOP to amplify AR signaling and promote prostate cancer.

Nature communications

Mukhopadhyay C,Yang C,Xu L,Liu D,Wang Y,Huang D,Deonarine LD,Cyrta J,Davicioni E,Sboner A,Robinson BD,Chinnaiyan AM,Rubin MA,Barbieri CE,Zhou P

Thu Nov 18 00:00:00 EST 2021

G3BP1 inhibits Cul3^SPOP to amplify AR signaling and promote prostate cancer.

Nature communications

Mukhopadhyay C,Yang C,Xu L,Liu D,Wang Y,Huang D,Deonarine LD,Cyrta J,Davicioni E,Sboner A,Robinson BD,Chinnaiyan AM,Rubin MA,Barbieri CE,Zhou P

Thu Nov 18 00:00:00 EST 2021

SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.

Nature communications

Ma J,Shi Q,Cui G,Sheng H,Botuyan MV,Zhou Y,Yan Y,He Y,Wang L,Wang Y,Mer G,Ye D,Wang C,Huang H

Fri Oct 01 00:00:00 EDT 2021

Genetic fusions favor tumorigenesis through degron loss in oncogenes.

Nature communications

Liu J,Tokheim C,Lee JD,Gan W,North BJ,Liu XS,Pandolfi PP,Wei W

Thu Nov 18 00:00:00 EST 2021

Genetic fusions favor tumorigenesis through degron loss in oncogenes.

Nature communications

Liu J,Tokheim C,Lee JD,Gan W,North BJ,Liu XS,Pandolfi PP,Wei W

Thu Nov 18 00:00:00 EST 2021

ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication.

Science advances

Wang D,Ma J,Botuyan MV,Cui G,Yan Y,Ding D,Zhou Y,Krueger EW,Pei J,Wu X,Wang L,Pei H,McNiven MA,Ye D,Mer G,Huang H

Tue Jun 01 00:00:00 EDT 2021

SPOP mutation induces DNA methylation via stabilizing GLP/G9a.

Nature communications

Zhang J,Gao K,Xie H,Wang D,Zhang P,Wei T,Yan Y,Pan Y,Ye W,Chen H,Shi Q,Li Y,Zhao SM,Hou X,Weroha SJ,Wang Y,Zhang J,Karnes RJ,He HH,Wang L,Wang C,Huang H

Wed Sep 29 00:00:00 EDT 2021

Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis.

Cancer cell international

He Y,Chen J,Peng X,Xia Y,Su Y

Sat Nov 27 00:00:00 EST 2021

Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer.

Nature communications

Wang W,Tang YA,Xiao Q,Lee WC,Cheng B,Niu Z,Oguz G,Feng M,Lee PL,Li B,Yang ZH,Chen YF,Lan P,Wu XJ,Yu Q

Wed Jul 21 00:00:00 EDT 2021

Hypoxia-induced SPOP attenuates the mobility of trophoblast cells through inhibition of the PI3K/AKT/GSK3β pathway.

Cell biology international

Yuan D,Yang Z,Chen Y,Li S,Tan B,Yu Q

Mon Mar 01 00:00:00 EST 2021

Hypoxia-induced SPOP attenuates the mobility of trophoblast cells through inhibition of the PI3K/AKT/GSK3β pathway.

Cell biology international

Yuan D,Yang Z,Chen Y,Li S,Tan B,Yu Q

Mon Mar 01 00:00:00 EST 2021

Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Zhang H,Xia Y,Wang F,Luo M,Yang K,Liang S,An S,Wu S,Yang C,Chen D,Xu M,Cai M,To KKW,Fu L

Sat May 01 00:00:00 EDT 2021

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.

Neoplasia (New York, N.Y.)

Luo Z,Wang J,Zhu Y,Sun X,He C,Cai M,Ma J,Wang Y,Han S

Fri Oct 01 00:00:00 EDT 2021

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.

Neoplasia (New York, N.Y.)

Luo Z,Wang J,Zhu Y,Sun X,He C,Cai M,Ma J,Wang Y,Han S

Fri Oct 01 00:00:00 EDT 2021

c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.